Diba names new general manager

Mick Pearson takes responsibility for the Cambridge, UK fluid handling component plant

To streamline operations at its Cambridge, UK plant and promote communication with its US headquarters, Diba Industries has named Mick Pearson as general manager.

Pearson will be responsible for the day-to-day operations at the fluid handling component manufacturing plant. He was previously business operations manager at Weetabix (Northamptonshire, UK) and site manager at Nampak Plastics Europe (Buckinghamshire, UK).

Diba, part of the multinational Halma technology group, provides custom engineered fluid handling components and design services. The company is headquartered in Danbury, Connecticut, US with global locations in the UK, China, and Japan.

You may also like

Manufacturing

Omnifit bottle cap traps harmful vapours

Integrated test strip indicates when to replace cap
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Manufacturing

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Manufacturing

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production
Manufacturing

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
Manufacturing

Symbiosis completes full ICH climatic zone coverage with new stability chamber addition

Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets
Subscribe now